Loading clinical trials...
Loading clinical trials...
A Phase 1, First-in-human, Randomized, Double-blind, Placebo-controlled, Single and Multiple Ascending Dose Study in Healthy Adults and Open-label Single Dose Study in Patients with Alzheimer's Diseas...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Vigil Neuroscience, Inc.
NCT05545306 · Obesity, Normal Physiology, and more
NCT07269301 · Hepatic Impairment, Healthy
NCT05877196 · Mild Cognitive Impairment, Alzheimer Disease, and more
NCT07554365 · Healthy Volunteer, Healthy Participants Study
NCT06096532 · Healthy, Aging
K2 Medical Research
Maitland, Florida
Clinical Pharmacology of Miami
Miami, Florida
Nucleus Network
Melbourne
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions